# Platelet Sub-study of the Neomindset Trial

> **NCT05767723** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Hospital Israelita Albert Einstein** · enrollment: 48 (estimated)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid + prasugrel
- **DRUG:** Monotherapy: Ticagrelor alone OR Prasugrel alone

## Key facts

- **NCT ID:** NCT05767723
- **Lead sponsor:** Hospital Israelita Albert Einstein
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-02-06
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05767723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05767723, "Platelet Sub-study of the Neomindset Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05767723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*